Jazz Pharma CEO Renee D. Gala sells 2,000 ordinary shares for $472,800
JAZZ•Jazz Pharmaceuticals President and CEO Renee D. Gala sold 2,000 ordinary shares on Oct. 6, 2026, for $472,800, at $236.40 per share. Her directly held stake fell to 141,394 shares.
1. Share sale
Gala sold 2,000 Jazz Pharmaceuticals ordinary shares on Oct. 6, 2026, at $236.40 per share, for a total of $472,800. Her directly held stake fell to 141,394 shares.
